2004
DOI: 10.1016/j.athoracsur.2003.08.027
|View full text |Cite
|
Sign up to set email alerts
|

The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
25
0
1

Year Published

2005
2005
2016
2016

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(26 citation statements)
references
References 19 publications
0
25
0
1
Order By: Relevance
“…This drug reduced the incidence of AF in 29% and of ventricular arrhythmia in 48% however, it did not reduce the time of hospitalization, the incidence of myocardial infarction or the mortality rate [11]. Another randomized study of 202 patients also concluded that the prophylactic administration of magnesium did not benefit patients sufficiently to recommend its routine utilization in heart surgeries [12].…”
Section: Discussionmentioning
confidence: 99%
“…This drug reduced the incidence of AF in 29% and of ventricular arrhythmia in 48% however, it did not reduce the time of hospitalization, the incidence of myocardial infarction or the mortality rate [11]. Another randomized study of 202 patients also concluded that the prophylactic administration of magnesium did not benefit patients sufficiently to recommend its routine utilization in heart surgeries [12].…”
Section: Discussionmentioning
confidence: 99%
“…Many authors have described the intravenous Mg infusion as a good method to correct hypomagnesaemia [10,[14][15][16]. Fanning et al [17] reported that the infusion of magnesium sulphate at the dose of 84 mmol/96 h reduced AF from 28% to 14.3% [17]; however, the decline was not statistically significant.…”
Section: Discussionmentioning
confidence: 99%
“…[18][19][20][21] However, several of these studies were limited by small sample size, improper blinding, and the use of a lower dose of Mg than in the current study. In fact, by combining studies on Mg prophylaxis in CABG surgery that were properly blinded and with sufficient patient sample sizes, Hazelrigg et al 34 failed to find an overall reduction in postoperative atrial or ventricular arrhythmias. Cook et al 35 were also unable to demonstrate a difference in the rate of clinically important atrial arrhythmia in patients receiving Mg versus placebo in addition to routine beta-blockade.…”
Section: Discussionmentioning
confidence: 99%